Literature DB >> 2421879

Complement-mediated lysis of K562 human leukemic cells by antibodies to phosphotyrosine and identification of cell surface proteins phosphorylated on tyrosine.

R Ogawa, M Ohtsuka, Y Watanabe.   

Abstract

Intact K562 human leukemic cells showed bright membrane immunofluorescence after staining with monoclonal antibody to O-phosphotyrosine (PTyr). Up to 60% of the cells were lysed with mouse, rabbit, or human antibodies to PTyr by a complement-mediated mechanism. A new method has been developed for identifying proteins that have PTyr residues on the outside of cell membrane, and at least two species of PTyr-containing proteins with the molecular weights of 45,000 and 36,000 were identified as the most probable candidates of the antigens responsible for the membrane fluorescence and cell lysis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2421879

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  4 in total

1.  Cell lines and peripheral blood leukocytes derived from individuals with chronic myelogenous leukemia display virtually identical proteins phosphorylated on tyrosine residues.

Authors:  R D Huhn; M R Posner; S I Rayter; J G Foulkes; A R Frackelton
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

2.  A 41-kilodalton protein is a potential substrate for the p210bcr-abl protein-tyrosine kinase in chronic myelogenous leukemia cells.

Authors:  E Freed; T Hunter
Journal:  Mol Cell Biol       Date:  1992-03       Impact factor: 4.272

3.  Tyrosine phosphorylation of an interleukin 2 receptor-like protein in cells transformed by human T cell leukemia virus type I.

Authors:  R Ogawa; K Sugamura; Y Watanabe
Journal:  J Exp Med       Date:  1987-04-01       Impact factor: 14.307

4.  Appearance of antibodies against phosphotyrosine and tyrosine phosphorylation of lymphocyte proteins in human T cell leukemia virus type-I infection.

Authors:  R Ogawa; T Koizumi; Y Nakao; M Sakitani; Y Watanabe; T Fujita
Journal:  Jpn J Cancer Res       Date:  1988-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.